IDiyas

For the Inventor, By the Inventor

Seattle, WA, United States of America

Stephen H Friend

USPTO Granted Patents = 30

 

Average Co-Inventor Count = 2.6

ph-index = 13

Forward Citations = 713(Granted Patents)


Location History:

  • Bryn Mawr, PA (US) (2007)
  • Somerville, MA (US) (1998 - 2008)
  • Philadelphia, PA (US) (2004 - 2011)
  • Seattle, WA (US) (1999 - 2020)

Company Filing History:

goldMedal15 out of 47 
 
Rosetta Inpharmatics, Inc.
 patents
silverMedal4 out of 289 
 
Fred Hutchinson Cancer Center
 patents
bronzeMedal3 out of 262 
 
Massachusetts Eye and Ear Infirmary
 patents
4. 3 out of 8 
 
Whitehead Institute
 patents
5. 2 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
6. 2 out of 15,458 
 
University of California
 patents
7. 2 out of 2 
 
Sage Bionetworks
 patents
8. 2 out of 189 
 
Cold Spring Harbor Laboratory
 patents
9. 1 out of 1 
 
Rosetta Impharmatics, Inc.
 patent
10. 1 out of 8 
 
The Netherlands Cancer Institute
 patents
11. 1 out of 54,638 
 
Microsoft Technology Licensing, LLC
 patents
12. 1 out of 4,770 
 
Merck + Co., Inc.
 patents
where one patent can have more than one assignee

Years Active: 1998-2020

Loading Chart...
Loading Chart...
30 patents (USPTO):
1. 10718025 - Methods for predicting age and identifying agents that induce or inhibit premature aging (2020-07-21),
2. 10087486 - Methods for predicting age and identifying agents that induce or inhibit premature aging (2018-10-02),
3. 8753811 - Method for making populations of defined nucleic acid molecules (2014-06-17),
4. 8133670 - Method for making populations of defined nucleic acid molecules (2012-03-13),
5. 8019552 - Classification of breast cancer patients using a combination of clinical criteria and informative genesets (2011-09-13),
6. 7807447 - Compositions and methods for exon profiling (2010-10-05),
7. 7599799 - Methods for using co-regulated genesets to enhance detection and classification of gene expression patterns (2009-10-06),
8. 7384735 - Retinoblastoma nucleic acids (2008-06-10),
9. 7223842 - Detection of proteins whose absence is associated with a neoplasm (2007-05-29),
10. 7173063 - Topoisomerase poisons for the treatment of proliferative disorders (2007-02-06),
11. 7130746 - Computer systems and computer programs for determining protein activity levels using gene expression profiles (2006-10-31),
12. 7122312 - Methods for drug target screening (2006-10-17),
13. 7013221 - Iterative probe design and detailed expression profiling with flexible in-situ synthesis arrays (2006-03-14),
14. 6973388 - Methods of diagnosing disease states using gene expression profiles (2005-12-06),
15. 6950752 - Methods for removing artifact from biological profiles (2005-09-27),

Title: The Innovative Journey of Stephen H Friend

Introduction: Stephen H Friend, a pioneering inventor hailing from Seattle, WA (US), has made significant contributions to the field of technology and healthcare through his groundbreaking innovations.

Latest Patents: Stephen H Friend's latest patents focus on cutting-edge medical technologies aimed at revolutionizing the way we approach healthcare and treatment methods.

Career Highlights: With a distinguished career spanning several decades, Stephen H Friend has held key positions in renowned research institutions and companies, where he has spearheaded numerous projects that have pushed the boundaries of innovation.

Collaborations: Throughout his career, Stephen H Friend has collaborated with leading experts in various fields, fostering a culture of innovation and knowledge-sharing that has led to remarkable advancements in technology and healthcare.

Conclusion: Stephen H Friend's relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his reputation as a visionary inventor at the forefront of technological and medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…